Neuropsychological Complications of Hypoprolactinemia

Overview

Journal Rev Endocr Metab Disord

Publisher Springer

Specialty Endocrinology

Date 2024 Jul 2

PMID 38955985

Authors

Vicki Munro

Michael Wilkinson

Syed Ali Imran

Affiliations

Soon will be listed here.

Abstract

Prolactin (PRL) is primarily produced by the pituitary lactotrophic cells and while initially named for its role in lactation, PRL has several other biological roles including immunomodulation, osmotic balance, angiogenesis, calcium metabolism, and appetite regulation. Most of the PRL-related literature has traditionally focused on hyperprolactinemia, whereas hypoprolactinemia has received little attention. There is evidence to suggest that PRL receptors are widely distributed within the central nervous system including the limbic system. Furthermore, PRL has been shown to play key role in the stress regulation pathway. Recent data also suggest that hypoprolactinemia may be associated with increased sexual dysfunction, anxiety, and depression. In this paper we discuss the current understanding regarding the neuropsychological impact of hypoprolactinemia and highlight the need for adequately defining hypoprolactinemia as an entity and consideration for future replacement therapies.

Citing Articles

Drug induced hypoprolactinemia.

Ioachimescu A, Kelestimur F Rev Endocr Metab Disord. 2024; 25(6):1003-1011.

PMID: 39312063 DOI: 10.1007/s11154-024-09909-6.

References

Kawauchi H, Sower S . The dawn and evolution of hormones in the adenohypophysis. Gen Comp Endocrinol. 2005; 148(1):3-14. DOI: 10.1016/j.ygcen.2005.10.011. View

Freeman M, Kanyicska B, Lerant A, Nagy G . Prolactin: structure, function, and regulation of secretion. Physiol Rev. 2000; 80(4):1523-631. DOI: 10.1152/physrev.2000.80.4.1523. View

Ben-Jonathan N, Mershon J, Allen D, Steinmetz R . Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev. 1996; 17(6):639-69. DOI: 10.1210/edrv-17-6-639. View

Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly P . Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev. 1998; 19(3):225-68. DOI: 10.1210/edrv.19.3.0334. View

Macotela Y, Triebel J, Clapp C . Time for a New Perspective on Prolactin in Metabolism. Trends Endocrinol Metab. 2020; 31(4):276-286. DOI: 10.1016/j.tem.2020.01.004. View

Wang T, Lu J, Xu Y, Li M, Sun J, Zhang J . Circulating prolactin associates with diabetes and impaired glucose regulation: a population-based study. Diabetes Care. 2013; 36(7):1974-80. PMC: 3687322. DOI: 10.2337/dc12-1893. View

Corona G, Mannucci E, Jannini E, Lotti F, Ricca V, Monami M . Hypoprolactinemia: a new clinical syndrome in patients with sexual dysfunction. J Sex Med. 2009; 6(5):1457-66. DOI: 10.1111/j.1743-6109.2008.01206.x. View

Krysiak R, Kowalcze K, Okopien B . Sexual function and depressive symptoms in men with hypoprolactinaemia secondary to overtreatment of prolactin excess: A pilot study. Endocrinol Diabetes Nutr (Engl Ed). 2022; 69(4):279-288. DOI: 10.1016/j.endien.2021.03.004. View

Toledano Y, Lubetsky A, Shimon I . Acquired prolactin deficiency in patients with disorders of the hypothalamic-pituitary axis. J Endocrinol Invest. 2007; 30(4):268-73. DOI: 10.1007/BF03346292. View

10.

Mukherjee A, Murray R, Columb B, Gleeson H, Shalet S . Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic-pituitary axis. Clin Endocrinol (Oxf). 2004; 59(6):743-8. DOI: 10.1046/j.1365-2265.2003.01916.x. View

11.

Mukherjee A, Murray R, Teasdale G, Shalet S . Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Clin Endocrinol (Oxf). 2004; 60(4):476-83. DOI: 10.1111/j.1365-2265.2004.02004.x. View

12.

Ioachimescu A, Fleseriu M, Hoffman A, Vaughan Iii T, Katznelson L . Psychological effects of dopamine agonist treatment in patients with hyperprolactinemia and prolactin-secreting adenomas. Eur J Endocrinol. 2018; 180(1):31-40. DOI: 10.1530/EJE-18-0682. View

13.

Roelfsema F, Pijl H, Keenan D, Veldhuis J . Prolactin secretion in healthy adults is determined by gender, age and body mass index. PLoS One. 2012; 7(2):e31305. PMC: 3281966. DOI: 10.1371/journal.pone.0031305. View

14.

Fleseriu M, Hashim I, Karavitaki N, Melmed S, Murad M, Salvatori R . Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016; 101(11):3888-3921. DOI: 10.1210/jc.2016-2118. View

15.

Kobayashi T, Usui H, Tanaka H, Shozu M . Variant Prolactin Receptor in Agalactia and Hyperprolactinemia. N Engl J Med. 2018; 379(23):2230-2236. DOI: 10.1056/NEJMoa1805171. View

16.

Carlson H, Brickman A, Bottazzo G . Prolactin deficiency in pseudohypoparathyroidism. N Engl J Med. 1977; 296(3):140-4. DOI: 10.1056/NEJM197701202960304. View

17.

Iwama S, Welt C, Romero C, Radovick S, Caturegli P . Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells. J Clin Endocrinol Metab. 2013; 98(10):3920-5. PMC: 3790613. DOI: 10.1210/jc.2013-2411. View

18.

Diri H, Tanriverdi F, Karaca Z, Senol S, Unluhizarci K, Durak A . Extensive investigation of 114 patients with Sheehan's syndrome: a continuing disorder. Eur J Endocrinol. 2014; 171(3):311-8. DOI: 10.1530/EJE-14-0244. View

19.

Di Carlo R, Muccioli G, Papotti M, Bussolati G . Characterization of prolactin receptor in human brain and choroid plexus. Brain Res. 1992; 570(1-2):341-6. DOI: 10.1016/0006-8993(92)90599-5. View

20.

Pathipati P, Gorba T, Scheepens A, Goffin V, Sun Y, Fraser M . Growth hormone and prolactin regulate human neural stem cell regenerative activity. Neuroscience. 2011; 190:409-27. DOI: 10.1016/j.neuroscience.2011.05.029. View